Core Viewpoint - The company *ST Zhengping has experienced significant stock price volatility, with a cumulative decline exceeding 12% over three consecutive trading days, indicating abnormal fluctuations in its stock performance [1] Financial Performance - In 2024, the company reported a revenue of 1.362 billion yuan and a net profit attributable to shareholders of -484 million yuan [1] - For the first three quarters of 2025, the company generated a revenue of 652 million yuan, with a net profit attributable to shareholders of -99 million yuan [1] Audit and Compliance Issues - The company has unresolved non-standard audit opinion matters for the 2024 fiscal year, which raises concerns about its financial reporting [1] - The acceptance of the pre-restructuring application remains uncertain, indicating potential challenges in financial restructuring [1] - The non-standard opinion in the Q3 2025 report is pending verification, suggesting ongoing scrutiny of the company's financial practices [1] Operational Risks - There are indications of potential fund occupation and illegal guarantees, which could pose significant risks to the company's financial stability [1] - The company faces insufficient mineral extraction capacity, which may hinder its operational effectiveness and growth prospects [1] - If the aforementioned issues are not resolved, there is a risk that the company's stock may be delisted [1]

全文请见：政府补助+跨界新能源+筹划重大资产重组，*ST生物能否跨过退市"生死线"？ 近期*ST生物发布获得政府补助资金480万元的公告。2024年*ST生物的营业收入不足3亿元，净利润为 亏损。根据退市新规，如果2025年*ST生物继续亏损且营收不及3亿元，那么其可能就会被实施退市处 理。今年9月份，*ST生物还收购了一家新能源公司，并且公司还有一项重大资产重组正在进行中。 *ST生物能否摆脱退市风险？每经资本眼专栏记者致电*ST生物董秘办，相关工作人员表示："近期公司 采取了一系列措施，一个是收购了娄底金弘，另外就是把一些不良资产处置了。四季度的盈利需要等年 底做完审计才能知道，尽管如此，公司肯定会采取一系列措施来改进现状的。" 每日经济新闻 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 每经记者|章光日 每经编辑|吴永久 近期*ST生物（维权）发布获得政府补助资金480万元的公告。2024年*ST生物的营业收入不足3亿元， 净利润为亏损。根据退市新规，如果2025年*ST生物继续亏损且营收不及3亿元，那么其可能就会被实 施退市处理。今年9月份，*ST生物还收购了一家新能源公司，并且公司还有一项重大资产重组正在进 行中。 *ST生物能否摆脱退市风险？接下来每经资本眼专栏记者就来详细探究一番。 2025年12月7日盘后，*ST生物发布了关于获得政府补助的公告。该公告显示，近期，公司收到一笔与 收益相关的政府补助资金共计480万元。 每经资本眼专栏记者发现，这笔政府补助有助于*ST生物摆脱被实施退市处理的风险。根据沪深交易所 修订后的《股票发行上市审核规则》，以2024年为首个起算年度，沪深主板上市公司若连续两年触 及"利润总额或扣非净利润为负且营业收入低于3亿元"的财务退市指标，将被实施退市处理。 目前，*ST生物形成了"生物医药+节能环保"双主业的业务发展格局。不过，2021年以来，*ST生物陷入 了持续亏损的困境。同花 ...

新大洲A（000571）债务危机仍无解。 12月8日，新大洲A股午后直线拉升涨停，股价创2017年以来新高。12月8日晚间，新大洲A再次公布了 其全资子公司债务逾期问题的进展。 根据新大洲A今年9月披露的公告：公司全资子公司新大洲（浙江）商贸有限公司（下称"浙江商 贸"），向华夏银行宁波分行（下称"华夏银行"）贷款8000万元。浙江商贸应于2025年9月10日支付到期 本金8000万元、利息104万元，但其并未及时偿还。 由于五九集团为新大洲A主要收入来源，该事项有可能导致公司触及《深圳证券交易所股票上市规则》 第9.3.1条之（一）最近一个会计年度经审计的利润总额、净利润、扣非净利润三者孰低为负值，且扣除 后的营业收入低于3亿元，触及退市风险警示情形。 新大洲A称，公司董事会将密切关注后续进展，避免出现风险警示的情形发生，并提示投资者关注相关 风险，谨慎投资。 新大洲A于1994年5月25日在深交所上市，公司主营业务为摩托车制造与销售。2006年12月，公司完成 对五九集团股权的收购，煤炭产业收入首度合并进入公司会计报表。 2017年，公司出售了新大洲本田摩托有限公司股权。自2007年以来，新大洲A主营业务 ...

根据新大洲A今年9月披露的公告：公司全资子公司新大洲（浙江）商贸有限公司（下称"浙江商 贸"），向华夏银行宁波分行（下称"华夏银行"）贷款8000万元。浙江商贸应于2025年9月10日支付到期 本金8000万元、利息104万元，但其并未及时偿还。 浙江商贸该笔借款，由新大洲A等提供连带责任保证担保。其中，新大洲A以持有的内蒙古牙克石五九 煤炭（集团）有限责任公司（下称"五九集团"）5400万元股权提供质押，质押期限自2022年9月2日至 2027年9月2日。 12月8日，新大洲A在最新公告中提到，公司在大股东大连和升控股集团有限公司的协助下，正在积极 与债权人及第三方等沟通，寻求解决方案。但从参与各方推进的情况看，截至目前，未达成可继续推进 的方案，上述债务逾期能否解决存在重大不确定性。 新大洲A表示，若上述逾期债务未能妥善解决，进入诉讼程序，受理法院之后做出的判决涉及执行公司 持有的五九集团股权，将可能导致公司失去五九集团控制权，继而导致公司无法合并五九集团财务报 表。 证券时报记者吴志 新大洲A(000571)债务危机仍无解。 12月8日，新大洲A股午后直线拉升涨停，股价创2017年以来新高。12月8日晚 ...

Core Viewpoint - New Dazhou A (000571) is facing an unresolved debt crisis, with its stock price reaching a multi-year high since 2017 on December 8, despite ongoing issues related to overdue debts of its wholly-owned subsidiary [1] Group 1: Debt Issues - New Dazhou's wholly-owned subsidiary, New Dazhou (Zhejiang) Trading Co., Ltd., borrowed 80 million yuan from Huaxia Bank Ningbo Branch, with a repayment due on September 10, 2025, including interest of 1.04 million yuan, which has not been repaid on time [3] - The loan is guaranteed by New Dazhou and others, with New Dazhou pledging its 54 million yuan equity in Inner Mongolia Yakeshi Wujiu Coal Group Co., Ltd. as collateral, valid from September 2, 2022, to September 2, 2027 [4] - As of December 8, New Dazhou is actively seeking solutions with creditors and third parties, but no viable plan has been reached, leading to significant uncertainty regarding the resolution of the overdue debt [4] Group 2: Financial Implications - If the overdue debt is not resolved and legal proceedings are initiated, the court's ruling could affect New Dazhou's control over Wujiu Group, potentially preventing the consolidation of Wujiu Group's financial statements [4] - Wujiu Group is a major source of revenue for New Dazhou, and failure to resolve the debt could trigger delisting risk under Shenzhen Stock Exchange rules if the company's audited profit totals for the last fiscal year fall below negative values [4] - New Dazhou reported a revenue of 820 million yuan for 2024, a nearly 33% decrease year-on-year, with a net loss of 111 million yuan, marking consecutive years of losses [5] Group 3: Business Overview - New Dazhou was listed on the Shenzhen Stock Exchange on May 25, 1994, primarily engaged in motorcycle manufacturing and sales, and has shifted its main business focus to coal mining and sales since 2007 [5] - Wujiu Group, acquired in 2006, has a production capacity of 3 million tons per year and produces long flame coal, which has a competitive market advantage in the eastern Mongolia region [5]

*ST正平9月以来累计26个交易日涨停。其间，该股三度停牌核查。 12月2日晚间，*ST正平（603843）公告称，公司近日就股票交易情况进行核查，鉴于相关核查工作已完成，经向上海证券交易所申请，公司股票 将于12月3日（星期三）开市起复牌。 从2025年9月1日至11月18日，*ST正平股票累计涨幅达221.93%，股票短期涨幅与同期上证指数、建筑行业存在严重偏离。股价上涨过快，积累了 较高的交易风险。为维护投资者利益，公司就股票交易情况进行停牌核查，于11月19日开市起停牌。 近期，有债权人申请对*ST正平预重整，截至本公告披露日，公司尚未收到法院关于受理预重整申请的相关法律文书，即申请人的预重整申请能否 被法院受理、公司能否进入重整程序均存在重大不确定性，公司提醒广大投资者注意相关投资风险。 *ST正平同时提到，公司近期收到上交所对公司2025年三季报有关事项的监管工作函。截至目前，年审会计师尚无法就外部借款利息、工程项目成 本费用计量准确性和完整性获取充分、恰当的审计证据。"如截至2025年度财务报告日，年审会计师仍无法就上述事项获取充分、恰当的审计证 据，可能导致无法对财务报表发表非无保留意见，公司 ...

Core Viewpoint - *ST Zhengping has experienced significant stock price fluctuations, with a cumulative increase of 221.93% from September 1 to November 18, 2025, leading to trading risks and subsequent stock suspension for investigation [1][5]. Group 1: Stock Performance and Trading Risks - The stock of *ST Zhengping has seen 26 consecutive trading days of gains since September, with three suspensions for investigation during this period [1][5]. - The company announced that its stock will resume trading on December 3, 2025, after completing the investigation into trading activities [1][5]. - The rapid increase in stock price has created a significant divergence from the Shanghai Composite Index and the construction industry, indicating heightened trading risks [1][5]. Group 2: Financial Performance and Audit Issues - In 2024, *ST Zhengping reported revenue of 1.362 billion yuan and a net loss attributable to shareholders of 484 million yuan, with a non-recurring net loss of 475 million yuan [4][8]. - For the first three quarters of 2025, the company achieved revenue of 652 million yuan and a net loss of 99 million yuan, with a non-recurring net loss of 190 million yuan [4][8]. - The 2024 annual report received an audit opinion that could not express an opinion due to limited audit scope, leading to a delisting risk warning for the stock [3][7]. Group 3: Operational Challenges and Future Uncertainties - The company faces significant uncertainties regarding its ability to develop mineral resources, as it lacks sufficient funds, personnel, and equipment for future mining operations [3][8]. - As of September 30, 2025, *ST Zhengping reported cash holdings of 72.3767 million yuan, with 30.2848 million yuan restricted due to various legal and operational issues, resulting in a high debt ratio of 92.49% [3][8]. - The company has received a mining license for its subsidiary but requires substantial investment for future development, which is currently uncertain due to multiple external factors [3][8].

Core Viewpoint - *ST Suwu has been delisted due to long-term financial fraud and information disclosure violations, with significant implications for its future operations and market presence [2][6]. Financial Misconduct - Since 2018, *ST Suwu has concealed its actual controlling shareholder and inflated its revenue by over 1.77 billion yuan through related party transactions [2][6]. - Approximately 1.69 billion yuan of funds have been non-operationally occupied by related parties, nearly depleting the company's core assets [2][6]. - The company has been fined 10 million yuan, and its actual controller has been fined 15 million yuan and banned from the securities market for 10 years [6]. Business Performance - The company's revenue has significantly declined, with a year-on-year drop of 38.85% in the first three quarters of 2025, resulting in a net loss of 87.468 million yuan [2][8]. - The traditional pharmaceutical sector has also suffered, with a 55.79% decline in revenue during the same period [8]. Legal and Regulatory Issues - In February 2023, *ST Suwu received a notice from the China Securities Regulatory Commission (CSRC) regarding suspected violations of information disclosure laws [5]. - The company faced a series of regulatory actions, including warnings and administrative penalties, culminating in its delisting [5][6]. Product and Market Challenges - The "Tongyan Needle" (AestheFill) has become a critical growth point for *ST Suwu, contributing 35.55% of its revenue in Q1 2025 [7][8]. - A dispute over the agency rights for AestheFill has emerged, with the company facing a potential loss of this key product due to a contract termination by a partner [7][8]. Future Outlook - With the delisting, *ST Suwu faces severe challenges in liquidity and creditworthiness, as it loses access to capital markets [9][10]. - The company must find new revenue sources quickly to survive, as its current financial situation is precarious, with only about 49.19 million yuan in cash remaining [9][10].

ST立方最新披露，公司被查明存在年报虚假记载，2021年至2023年累计虚增营收超6亿元，安徽证 监局对公司及10名相关责任人合计罚款4000万元，多人被采取10年市场禁入措施。 记者关注到，在此番被查明财务造假之前，ST立方去年至今两度更正会计差错，2024年年报被出 具"非标"意见，今年4月底被实施ST。 2025.11. 30 本文字数：2666，阅读时长大约4分钟 作者 | 第一财经 周楠 连续三年虚增营收，其中两年的虚增金额占到当期总营收五成以上，控股股东正在推进破产重整的 ST立方（300344.SZ），因上述财务造假问题吃下大额罚单，并由此拉响退市"警钟"。 如今，ST立方在"戴帽"半年之后还将"披星"。根据安排，该股将于12月1日开市起停牌，次日复牌后 股票简称变更为*ST立方。公司同时提到， 若后续正式处罚出炉，公司被认定触及重大违法强制退 市情形，将被终止上市。 基本面上，ST立方已亏损累累，近五年扣非净利润累计亏损超10亿元。公司控股股东正在推进破产 重整，持股5%以上股东的部分持股近期则遭遇流拍。 连续三年财务造假 早前，ST立方4月底披露，公司因定期报告涉嫌信披违法违规被证监会立案。 ...